Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hemann, Michael T."'
Autor:
Miller AB; Harvard-MIT Department of Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Boston, MA, USA.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Rodriguez FH; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Langenbucher A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Computation and Systems Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Lin L; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Bray C; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Duquette S; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Zhang Y; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Goulet D; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Lane AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Merck and Co., Rahway, NJ, USA., Hemann MT; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. hemann@mit.edu.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. hemann@mit.edu., Manalis SR; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. srm@mit.edu.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. srm@mit.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. srm@mit.edu.; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. srm@mit.edu.
Publikováno v:
Communications biology [Commun Biol] 2024 Apr 20; Vol. 7 (1), pp. 483. Date of Electronic Publication: 2024 Apr 20.
Autor:
Chen CC; Stem Cell Transplantation Program, Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Silberman RE; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; RA Capital, Boston, MA, USA., Ma D; The Barbara K. Ostrom (1978) Bioinformatics and Computing Facility, Swanson Biotechnology Center, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Perry JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Khalid D; Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Amon A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA, USA., Hemann MT; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. hemann@mit.edu.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. hemann@mit.edu., Rowe RG; Stem Cell Transplantation Program, Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. grant_rowe@dfci.harvard.edu.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. grant_rowe@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. grant_rowe@dfci.harvard.edu.
Publikováno v:
Leukemia [Leukemia] 2024 Mar; Vol. 38 (3), pp. 521-529. Date of Electronic Publication: 2024 Jan 20.
Autor:
Roux B; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Vaganay C; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Vargas JD; Cleave Therapeutics Inc., San Francisco, CA 94105, USA., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Benaksas C; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Pardieu B; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Fenouille N; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Ellegast JM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Malolepsza E; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Ling F; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Sodaro G; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Ross L; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Tang Y; Cleave Therapeutics Inc., San Francisco, CA 94105, USA., Wu T; Cleave Therapeutics Inc., San Francisco, CA 94105, USA., Anderson DJ; Cleave Therapeutics Inc., San Francisco, CA 94105, USA., Le Moigne R; Cleave Therapeutics Inc., San Francisco, CA 94105, USA., Zhou HJ; Cleave Therapeutics Inc., San Francisco, CA 94105, USA., Luciano F; IRCAN, INSERM U1081 and CNRS UMR 7284, 06189 Nice, France., Hartigan CR; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Galinsky I; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Auberger P; C3M, INSERM U1065, Team Cell Death, Differentiation, Inflammation and Cancer, 06204 Nice, France., Schenone M; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Carr SA; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Guirouilh-Barbat J; Université de Paris, INSERM U1016 and CNRS UMR 8104, Institut Cochin, 75014 Paris, France., Lopez B; Université de Paris, INSERM U1016 and CNRS UMR 8104, Institut Cochin, 75014 Paris, France., Khaled M; INSERM U1186, Gustave-Roussy Cancer Center, Université Paris-Saclay, 94805 Villejuif, France., Lage K; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Hermine O; Université de Paris, INSERM U1163 and CNRS 8254, Institut Imagine, Hôpital Necker, APHP, 75015 Paris, France., Hemann MT; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Puissant A; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France. lina.benajiba@inserm.fr kimberly_stegmaier@dfci.harvard.edu alexandre.puissant@inserm.fr., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA. lina.benajiba@inserm.fr kimberly_stegmaier@dfci.harvard.edu alexandre.puissant@inserm.fr.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Benajiba L; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France. lina.benajiba@inserm.fr kimberly_stegmaier@dfci.harvard.edu alexandre.puissant@inserm.fr.
Publikováno v:
Science translational medicine [Sci Transl Med] 2021 Mar 31; Vol. 13 (587).
Autor:
Benajiba L; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA, USA.; INSERM U1163 and CNRS 8254, Imagine Institute, Université Paris Saclay, Paris, France., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA, USA.; Bioinformatics Graduate Program, Boston University, Boston, MA, USA., Su A; INSERM UMR 944, Institut Universitaire d'Hématologie, Hôpital St. Louis, Paris, France., Raffoux E; Département d'Hématologie, Hôpital Saint-Louis, Assistance Publique - Hopitaux de Paris, Paris, France., Soulier J; Département d'Hématologie, Hôpital Saint-Louis, Assistance Publique - Hopitaux de Paris, Paris, France., Hemann MT; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA, USA., Hermine O; INSERM U1163 and CNRS 8254, Imagine Institute, Université Paris Saclay, Paris, France., Itzykson R; INSERM UMR 944, Institut Universitaire d'Hématologie, Hôpital St. Louis, Paris, France.; Département d'Hématologie, Hôpital Saint-Louis, Assistance Publique - Hopitaux de Paris, Paris, France., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. Kimberly_Stegmaier@dfci.harvard.edu.; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA, USA. Kimberly_Stegmaier@dfci.harvard.edu., Puissant A; INSERM UMR 944, Institut Universitaire d'Hématologie, Hôpital St. Louis, Paris, France. alexandre.puissant@inserm.fr.
Publikováno v:
Leukemia [Leukemia] 2019 Mar; Vol. 33 (3), pp. 800-804. Date of Electronic Publication: 2018 Nov 02.
Autor:
Wagner FF; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA. fwagner@broadinstitute.org kimberly_stegmaier@dfci.harvard.edu., Benajiba L; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.; INSERM U1163 and CNRS 8254, Imagine Institute, Université Paris Saclay, 91190 Paris, France., Campbell AJ; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA., Weïwer M; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA., Sacher JR; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA., Gale JP; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA., Ross L; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA., Puissant A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.; INSERM U944, Institute of Hematology, St. Louis Hospital, 75010 Paris, France., Alexe G; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.; Bioinformatics Graduate Program, Boston University, Boston, MA 02215, USA., Conway A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA., Back M; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA., Pikman Y; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA., Galinsky I; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Kaya T; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA., Shi X; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA., Robers MB; Promega Corporation, 2800 Woods Hollow Road, Madison, WI 53711, USA., Machleidt T; Promega Corporation, 2800 Woods Hollow Road, Madison, WI 53711, USA., Wilkinson J; Promega Corporation, 2800 Woods Hollow Road, Madison, WI 53711, USA., Hermine O; INSERM U1163 and CNRS 8254, Imagine Institute, Université Sorbonne Paris Cité, Paris, France.; Department of Hematology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, University Paris Descartes, 75006 Paris, France., Kung A; Department of Pediatrics, Columbia University Medical Center, New York, NY 10032, USA., Stein AJ; Cayman Chemical Co., Ann Arbor, MI 48108, USA., Lakshminarasimhan D; Xtal BioStructures Inc., Natick, MA 01760, USA., Hemann MT; Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Scolnick E; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA., Zhang YL; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA., Pan JQ; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA., Stegmaier K; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA. fwagner@broadinstitute.org kimberly_stegmaier@dfci.harvard.edu.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA., Holson EB; Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2018 Mar 07; Vol. 10 (431).
Autor:
Fenouille N; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Bassil CF; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ben-Sahra I; Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts, USA., Benajiba L; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Bioinformatics Graduate Program, Boston University, Boston, Massachusetts, USA., Ramos A; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Burgess MR; Department of Medicine, University of California San Francisco, San Francisco, California, USA., Li Q; Internal Medicine Hematology-Oncology, University of Michigan, Ann Arbor, Michigan, USA., Luciano F; Université Côte d'Azur, UMR INSERM U1065, C3M, Nice, France., Auberger P; Université Côte d'Azur, UMR INSERM U1065, C3M, Nice, France., Galinsky I; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Zhang Y; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, New York, USA., Perkins AS; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, New York, USA., Shannon K; Department of Pediatrics and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Hemann MT; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Puissant A; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; INSERM UMR 944, Institut Universitaire d'Hématologie, Hôpital St. Louis, Paris, France., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Publikováno v:
Nature medicine [Nat Med] 2017 Mar; Vol. 23 (3), pp. 301-313. Date of Electronic Publication: 2017 Feb 13.
Autor:
Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215., Puissant A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215 Institut National de la Santé et de la Recherche Medicale U1065, Team 2, C3M, 06204 Nice, France., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215 Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142 Bioinformatics Graduate Program, Boston University, Boston, MA 02215., Furman A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215., Chen LM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215., Frumm SM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215., Ross L; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215., Fenouille N; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02142., Bassil CF; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215., Lewis CA; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02142., Ramos A; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02142., Gould J; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Galinsky I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Clish CB; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142., Kung AL; Department of Pediatrics, Columbia University Medical Center, New York, NY 10032., Hemann MT; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02142., Vander Heiden MG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142 Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02142., Banerji V; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215 Research Institute of Oncology and Hematology at CancerCare Manitoba and the University of Manitoba, Winnipeg R3E OV9, Manitoba, Canada., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215 Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215 Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142 kimberly_stegmaier@dfci.harvard.edu.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2016 Jun 27; Vol. 213 (7), pp. 1285-306. Date of Electronic Publication: 2016 Jun 20.
Autor:
Puissant A; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA., Fenouille N; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Bioinformatics Graduate Program, Boston University, Boston, MA 02215, USA., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA., Bassil CF; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA., Mehta S; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA., Du J; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Kazi JU; Experimental Clinical Chemistry, Department of Laboratory Medicine, Lund University, Medicon Village, 221 00 Lund, Sweden., Luciano F; C3M/ INSERM U1065 Team Cell Death, Differentiation, Inflammation and Cancer, 06204 Nice, France., Rönnstrand L; Experimental Clinical Chemistry, Department of Laboratory Medicine, Lund University, Medicon Village, 221 00 Lund, Sweden., Kung AL; Pediatric Department, Columbia University Medical Center, New York, NY 10032, USA., Aster JC; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA., Galinsky I; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Hemann MT; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Electronic address: kimberly_stegmaier@dfci.harvard.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2014 Feb 10; Vol. 25 (2), pp. 226-42.